E. Trachte et al., WASHING AND TRYPSIN TREATMENT OF IN-VITRO DERIVED BOVINE EMBRYOS EXPOSED TO BOVINE VIRAL DIARRHEA VIRUS, Theriogenology, 50(5), 1998, pp. 717-726
Gametes, somatic cells and materials of animal origin in media are pot
ential sources for introducing bovine viral diarrhea virus (BVDV) into
systems for production of IVF bovine embryos. Further, the efficacy o
f washing and trypsin treatment for removal of BVDV from IVF embryos i
s questionable. Washing and trypsin treatments recommended by the Inte
rnational Embryo Transfer Society for in vivo-derived embryos were app
lied to in vitro-derived, virus-exposed, bovine embryos in this side-b
y-side comparison of treatments. Embryos for the study were produced i
n a virus-free system in which follicular oocytes were matured and fer
tilized in vitro and presumptive zygotes were co-cultured with bovine
uterine tubal cells for 7 d. A total of 18 trials was performed, 9 usi
ng a noncytopathic BVDV and 9 using a cytopathic BVDV. In each trial,
4 equal groups of 10 or less, zona pellucida-intact embryos/ova were a
ssembled, including 2 groups of morulae and blastocysts (M/B) and 2 gr
oups of nonfertile or degenerated ova (NFD). Each group was prewashed
and exposed to 10(4) to 10(6) TCID50/mL of either noncytopathic (SD-1)
or cytopathic (NADL) BVDV for 2 h. Following in vitro viral exposure,
one group of M/B and one group of NFD were washed. The other groups o
f M/B and NFD were trypsin-treated, Both treatments were consistent wi
th IETS guidelines. After in vitro exposure to noncytopathic BVDV and
washing, viral assays of 100 % (9/9) and 78 % (7/9) of the groups of M
/B and NFD ova, respectively, were positive. After in vitro exposure t
o cytopathic BVDV and washing, viral assay of 33 % (3/9) of the groups
of both M/B and NFD ova were positive. After in vitro exposure to non
cytopathic BVDV and trypsin treatment, viral assay of 44 % (4/9) of gr
oups of M/B and 67 % (6/9) of groups of NFD ova were positive. Finally
, after in vitro exposure to cytopathic BVDV and trypsin treatment, vi
ral assay of 22 % (2/9) of the groups of M/B and 44 % (4/9) of the gro
ups of NFD ova were positive. Contingency table analysis, in which dat
a was stratified by embryo type and virus biotype, was used to compare
results. While a difference existed between results of the 2 treatmen
ts of groups of M/B within the noncytopathic biotype (P = 0.01, Mantel
Haenszel Chi-square), no difference was observed between comparison o
f treatment between all groups in both biotypes (P > 0.05). (C) 1998 b
y Elsevier Science Inc.